Pfizer has announced that its vaccine is 95% effective on the basis of its Phase-3 trials. On Friday, Pfizer said that it is asking US regulators to allow the emergency use of its Covid-19 vaccine.
The company announced that they will submit a request to the US Food and Drug Administration (FDA) for Emergency Use Authorisation, which will potentially enable the use of the vaccine in high-risk populations in the US by mid to end of December 2020.
“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of Covid-19 globally. Filing in the US represents a critical milestone in our journey to deliver a Covid-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr Albert Borla, Pfizer CEO and chairman.
TikTok shuts down in the U.S. following a federal ban. Users report blocked access across…
Dakota Johnson, in Mumbai with boyfriend Chris Martin for Coldplay's tour, visits temples, shops, and…
A viral video showcasing a driverless auto rickshaw moving through Delhi's bustling streets has captivated…
A giant 15-foot bronze statue of Donald Trump’s iconic fist pump moment has been unveiled…
Elon Musk introduces "Make Europe Great Again" slogan while the EU investigates his platform X's…
Coldplay’s Chris Martin surprised fans during the band’s Mumbai concert by saying “Jai Shri Ram,”…